H2AX and adenocarcinoma: Notably, inhibition of USP28 in human adenocarcinoma cell lines, and in the SCC line SiHa, which does not express ∆Np63, led to a reduction of ɣ-H2AX, and co-treatment with cisplatin had no additive nor synergistic effect.